A large 2026 cohort study found that adolescents reporting cannabis use were more likely to later receive diagnoses of psychotic, bipolar, depressive, and anxiety disorders. This Evidence Watch review explains what the paper actually shows, where the associations are strongest, and why the findings deserve clinical attention. It also makes clear what the study does not prove, especially around causality, product type, and individual risk.